Studies of leukotriene antagonists and synthesis inhibitors in man.
Barnes
N
N
London Chest Hosp., England.
Evans
J
J
Zakrzewski
J
J
Piper
P
P
Costello
J
J
D000098:Acetophenones / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D002867:Chromones / Q000627:therapeutic use; D011464:Epoprostenol / Q000627:therapeutic use / Q000031:analogs & derivatives; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use; D007651:Keto Acids; D007975:Leukotriene B4 / Q000037:antagonists & inhibitors*; D010654:Phenylbutyrates / Q000627:therapeutic use; D011804:Quinolines; D013189:SRS-A / Q000037:antagonists & inhibitors*; D013450:Sulfones; D013777:Tetrazoles / Q000627:therapeutic use
D000098:Acetophenones; D002867:Chromones; D006912:Hydroxyquinolines; D007651:Keto Acids; D010654:Phenylbutyrates; D011804:Quinolines; D013189:SRS-A; D013450:Sulfones; D013777:Tetrazoles; C049740:alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol; D007975:Leukotriene B4; C044660:LY 171883; C006312:FPL 55712; C052024:L 648051; C050033:L 649923; D011464:Epoprostenol; C035296:piriprost